Investigation of systemic immune-inflammation index and systemic inflammation response index as an indicator of the anti-inflammatuary effect of isotretinoin in patients with acne vulgaris

References

• Zaenglein AL. Acne vulgaris. N Engl J Med 2018; 379:1343–1352.
   PubMed Web of Science ®Google Scholar
• Brelsford M, Beute TC. Preventing and managing the side effects of isotretinoin. Semin Cutan Med Surg 2008;27:197–206.
   PubMed Web of Science ®Google Scholar
• Thielitz A, Krautheim A, Gollnick H. Update in retinoid therapy of acne. Dermatol Ther 2006;19:272–279.
   PubMed Web of Science ®Google Scholar
• Kelhälä HL, Fyhrquist N, Palatsi R, et al. Isotretinoin treatment reduces acne lesions but not directly lesional acne inflammation. Exp Dermatol 2016;25:477–478.
   PubMed Web of Science ®Google Scholar
• Lee YH, Scharnitz TP, Muscat J, et al. Laboratory monitoring during isotretinoin therapy for acne: a systematic review and Meta-analysis. JAMA Dermatol 2016;152:35–44.
   PubMed Web of Science ®Google Scholar
• Zane LT, Leyden WA, Marqueling AL, et al. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol 2006;142:1016–1022.
   PubMed Web of Science ®Google Scholar
• Avci A, Avci D, Erden F, et al. Can we use the neutrophil-tolymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume values for the diagnosis of anterior uveitis in patients with Behcet’s disease? TCRM 2017;13:881–886.
   Google Scholar
• Altunisik N, Turkmen D, Sener S. Investigation of the relationship between inflammatory blood parameters and rosacea and demodex infestation. J Cosmet Dermatol 2020;19:2105–2108.
   PubMedGoogle Scholar
• Ataseven A, Kurtipek GS, Ozturk P. Neutrophil lymphocyte ratio in patients receiving isotretinoin for acne vulgaris. Med-Science 2014;3:1026–1031.
   Google Scholar
• Kutlu Ö. Effect of isotretinoin treatment on the inflammatory markers in patients with acne vulgaris: can monocyte/HDL be a new indicator for inflammatory activity of isotretinoin treatment? Cutan Ocul Toxicol 2020;39:67–70.
   PubMedGoogle Scholar
• Metin N., Turan Ç Ç. Increases in uric acid and monocyte-high-density lipoprotein ratio as possible atherosclerotic indicators in acne patients using isotretinoin. J Cosmet Dermatol 2021;20:2945–2949.
   PubMedGoogle Scholar
• Önder S, Ozturk M. Can monocyte/HDL show inflammatory activity of isotretinoin treatment in acne patients? Cutan Ocul Toxicol 2020;39:111–114.
   PubMed Web of Science ®Google Scholar
• Yang R, Chang Q, Meng X, et al. Prognostic value of systemic immune-inflammation index in cancer: a meta-analysis. J Cancer 2018;9:3295–3302.
   PubMed Web of Science ®Google Scholar
• Trifan G, Testai FD. Systemic immuneinflammation (SII) index predicts poor outcome after spontaneous supratentorial intracerebral hemorrhage. J Stroke Cerebrovasc Dis 2020;29:105057.
   PubMed Web of Science ®Google Scholar
• Dincer Rota D, Tanacan E. The utility of systemic-immune inflammation index for predicting the disease activation in patients with psoriasis. Int J Clin Pract 2021;75:e14101.
   PubMed Web of Science ®Google Scholar
• Tanacan E, Dincer D, Erdogan FG, et al. A cutoff value for the Systemic Immune-Inflammation Index in determining activity of Behçet disease. Clin Exp Dermatol 2021;46:286–291.
   PubMed Web of Science ®Google Scholar
• Tanghetti EA. The role of inflammation in the pathology of acne. J Clin Aesthet Dermatol 2013; 6:27–35.
   PubMedGoogle Scholar
• Karadag A, Ertugrul D, Bilgili S, et al. Immunoregulatory effects of isotretinoin in patients with acne. Br J Dermatol 2012; 167:433–435.
   PubMed Web of Science ®Google Scholar
• Brzezinski P, Borowska K, Chiriac A, et al. Adverse effects of isotretinoin: a large, retrospective review. Dermatol Ther 2017; 30:12483.
   Web of Science ®Google Scholar
• Waisman M. Agranulocytosis from isotretinoin. J Am Acad Dermatol 1988;18:395–396.
   PubMedGoogle Scholar
• Hansen TJ, Lucking S, Miller JJ, et al. Standardized laboratory monitoring with use of isotretinoin in acne. J Am Acad Dermatol 2016;75:323–328.
   PubMed Web of Science ®Google Scholar
• Layton A. The use of isotretinoin in acne. Dermatoendocrinol 2009;1:162–169.
   PubMedGoogle Scholar
• Seckin HY, Bas Y, Takcı Z, et al. Effects of isotretinoin on the inflammatory markers and the platelet counts in patients with acne vulgaris. Cutan Ocul Toxicol 2016;35:89–91.
   PubMed Web of Science ®Google Scholar
• Ozuguz P, Dogruk Kacar S, Polat S, et al. Evaluation of the efficacy of isotretinoin treatment on neutrophil/lymphocyte ratio and the other hemogram parameters. Mustafa Kemal Univ Tip Derg 2013;13:9–14.
   Google Scholar
• Ataseven A, Ugur Bilgin A. Effects of isotretinoin on the platelet counts and the mean platelet volume in patients with acne vulgaris. ScientificWorldJournal 2014;2014:156464.
   PubMedGoogle Scholar
• Tamer F, Yuksel ME, Avcı E. Is mean platelet volume an inflammatory marker in acne patients treated with isotretinoin? Acta Dermatovenerol Alp Pannonica Adriat 2019;28:65–69.
   PubMed Web of Science ®Google Scholar
• Yaldız M, Etinkaya Solak CR. B. Assessment of hematological and inflammatory parameters in patients receiving isotretinoin therapy for acne vulgaris. Mustafa Kemal Univ Tıp Derg 2018;9:61–67.
   Google Scholar
• Kim JW, Jung JY, Suh CH, et al. Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still's disease. Clin Rheumatol. 2021;40:661–668.
   PubMedGoogle Scholar
• Chao B, Ju X, Zhang L, et al. A novel prognostic marker Systemic Inflammation Response Index (SIRI) for operable cervical cancer patients. Front Oncol 2020;10:766.
   PubMed Web of Science ®Google Scholar
• Chen L, Chen Y, Zhang L, et al. In gastric cancer patients receiving neoadjuvant chemotherapy systemic inflammation response index is a useful prognostic indicator. Pathol Oncol Res 2021;27:1609811.
   PubMed Web of Science ®Google Scholar